• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症中努力分配受损。

Impaired effort allocation in schizophrenia.

作者信息

Blouzard Elodie, Cignetti Fabien, Meyniel Florent, Pouchon Arnaud, Polosan Mircea, Bastin Julien, Dondé Clément

机构信息

Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, 38000 Grenoble, France.

INSERM-CEA Cognitive Neuroimaging Unit (UNICOG), NeuroSpin Center, CEA Paris-Saclay, Gif-sur-Yvette, France Université de Paris, Paris 91191, France.

出版信息

Schizophr Res Cogn. 2025 Jul 15;42:100378. doi: 10.1016/j.scog.2025.100378. eCollection 2025 Dec.

DOI:10.1016/j.scog.2025.100378
PMID:40697646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12282204/
Abstract

BACKGROUND AND HYPOTHESIS

Effort allocation is a crucial component of amotivation in schizophrenia. This study investigates the hypothesis that schizophrenia is associated with impairments in dynamic cost/benefit decision-making processes.

STUDY DESIGN

We employed a modified version of the effort allocation task developed by Meyniel et al. (2013). Participants were asked to allocate effort during 30-s intervals to maximize their gains. We examined the effects of task difficulty and incentive levels on participants' effort allocation on a trial-by-trial basis.

STUDY RESULTS

Individuals with schizophrenia ( = 25) showed decreased capacity to adapt dynamically to task parameters, as compared to healthy controls (N = 25). (1) Both populations increased the duration of each effort based on difficulty. Only healthy controls decreased rest duration based on incentive. The magnitude of these adaptations was significantly decreased in people with schizophrenia (difficulty: d = 1.25, incentive: d = 0.91). (2) Both groups decreased effort re-initiations with increasing difficulty with significant differences in the magnitude of adaptation between groups. (3) Participants with schizophrenia spent less time exerting effort above the required threshold, resulting in lower overall gains compared to healthy controls (η = 0.17).

CONCLUSIONS

Individuals with schizophrenia exhibit a selective impairment in effort-cost decision-making. This deficit may contribute to maladaptive behavior patterns characterized by suboptimal effort allocation and reduced goal-direct activities.

摘要

背景与假设

努力分配是精神分裂症动机缺乏的一个关键组成部分。本研究调查了精神分裂症与动态成本/收益决策过程受损相关的假设。

研究设计

我们采用了Meyniel等人(2013年)开发的努力分配任务的修改版本。要求参与者在30秒的时间间隔内分配努力,以实现收益最大化。我们逐次试验地研究了任务难度和激励水平对参与者努力分配的影响。

研究结果

与健康对照组(N = 25)相比,精神分裂症患者(n = 25)动态适应任务参数的能力下降。(1)两组人群都根据难度增加了每次努力的持续时间。只有健康对照组根据激励减少了休息时间。精神分裂症患者这些适应的幅度显著降低(难度:d = 1.25,激励:d = 0.91)。(2)两组都随着难度增加而减少了努力的重新开始,两组之间适应幅度存在显著差异。(3)与健康对照组相比,精神分裂症患者在超过所需阈值的情况下花费在努力上的时间更少,导致总体收益更低(η = 0.17)。

结论

精神分裂症患者在努力成本决策方面表现出选择性损伤。这种缺陷可能导致以努力分配次优和目标导向活动减少为特征的适应不良行为模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5835/12282204/c72ba18a7bcd/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5835/12282204/b50d6a741049/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5835/12282204/d9acfe46bec0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5835/12282204/aec818129a5d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5835/12282204/c72ba18a7bcd/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5835/12282204/b50d6a741049/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5835/12282204/d9acfe46bec0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5835/12282204/aec818129a5d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5835/12282204/c72ba18a7bcd/gr4.jpg

相似文献

1
Impaired effort allocation in schizophrenia.精神分裂症中努力分配受损。
Schizophr Res Cogn. 2025 Jul 15;42:100378. doi: 10.1016/j.scog.2025.100378. eCollection 2025 Dec.
2
Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.抗精神病药治疗伴有紧张症症状的精神分裂症谱系障碍。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD013100. doi: 10.1002/14651858.CD013100.pub2.
3
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
4
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
5
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
6
Shared decision-making interventions for people with mental health conditions.心理健康问题患者的共同决策干预措施。
Cochrane Database Syst Rev. 2022 Nov 11;11(11):CD007297. doi: 10.1002/14651858.CD007297.pub3.
7
Early intervention for psychosis.精神病的早期干预
Cochrane Database Syst Rev. 2006 Oct 18(4):CD004718. doi: 10.1002/14651858.CD004718.pub2.
8
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
9
Selective noradrenaline reuptake inhibitors for schizophrenia.用于治疗精神分裂症的选择性去甲肾上腺素再摄取抑制剂。
Cochrane Database Syst Rev. 2018 Jan 25;1(1):CD010219. doi: 10.1002/14651858.CD010219.pub2.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.

本文引用的文献

1
Negative symptoms and cognitive impairment are associated with distinct motivational deficits in treatment resistant schizophrenia.阴性症状和认知障碍与治疗抵抗性精神分裂症中的不同动机缺陷有关。
Mol Psychiatry. 2023 Nov;28(11):4831-4841. doi: 10.1038/s41380-023-02232-7. Epub 2023 Aug 25.
2
Effort-Cost Decision-making Among Individuals With Schizophrenia: A Systematic Review and Meta-analysis.精神分裂症个体的努力-成本决策:系统评价和荟萃分析。
JAMA Psychiatry. 2023 Jun 1;80(6):548-557. doi: 10.1001/jamapsychiatry.2023.0553.
3
Efficacy of Serotonin and Dopamine Activity Modulators in the Treatment of Negative Symptoms in Schizophrenia: A Rapid Review.
5-羟色胺和多巴胺活性调节剂治疗精神分裂症阴性症状的疗效:快速综述
Biomedicines. 2023 Mar 16;11(3):921. doi: 10.3390/biomedicines11030921.
4
Early auditory processing dysfunction in schizophrenia: Mechanisms and implications.精神分裂症的早期听觉加工功能障碍:机制与意义。
Neurosci Biobehav Rev. 2023 May;148:105098. doi: 10.1016/j.neubiorev.2023.105098. Epub 2023 Feb 14.
5
A neuro-metabolic account of why daylong cognitive work alters the control of economic decisions.一种神经代谢解释为什么整日的认知工作会改变经济决策的控制。
Curr Biol. 2022 Aug 22;32(16):3564-3575.e5. doi: 10.1016/j.cub.2022.07.010. Epub 2022 Aug 11.
6
Schizophrenia.精神分裂症。
Lancet. 2022 Jan 29;399(10323):473-486. doi: 10.1016/S0140-6736(21)01730-X.
7
Filling the gaps: Cognitive control as a critical lens for understanding mechanisms of value-based decision-making.填补空白:认知控制作为理解基于价值的决策机制的关键视角。
Neurosci Biobehav Rev. 2022 Mar;134:104483. doi: 10.1016/j.neubiorev.2021.12.006. Epub 2021 Dec 10.
8
Validity and reliability of the Vigour Assessment Scale in avolitional schizophrenia outpatients.意志缺失型精神分裂症门诊患者活力评估量表的效度和信度。
Schizophr Res. 2021 Sep;235:36-43. doi: 10.1016/j.schres.2021.07.018. Epub 2021 Jul 22.
9
Psychomotor Slowing in Schizophrenia: Implications for Endophenotype and Biomarker Development.精神分裂症中的精神运动迟缓:对内表型和生物标志物开发的意义。
Biomark Neuropsychiatry. 2020 Jun;2. doi: 10.1016/j.bionps.2020.100016. Epub 2020 May 12.
10
Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development.意志缺乏作为精神分裂症的核心阴性症状:与药物治疗研发的相关性。
NPJ Schizophr. 2021 Feb 26;7(1):16. doi: 10.1038/s41537-021-00145-4.